(Q48900198)

16 February 2018

title

Clinical and demographic predictors of improvement during duloxetine treatment in patients with major depression: an open-label study. (English)

1 reference

16 February 2018

Alessandro Serretti

3

0 references

author name string

Elena Di Nasso

1

1 reference

16 February 2018

Alberto Chiesa

2

1 reference

16 February 2018

Diana De Ronchi

4

1 reference

16 February 2018

Claudio Mencacci

5

1 reference

16 February 2018

publication date

1 January 2011

1 reference

16 February 2018

Clinical Drug Investigation

published in

1 reference

16 February 2018

volume

31

1 reference

16 February 2018

issue

6

1 reference

16 February 2018

page(s)

385-405

1 reference

16 February 2018

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Predictors of drug response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Comorbidity and depression treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Personality disorder and the outcome of depression: meta-analysis of published studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

The impact of medical comorbidity on acute treatment in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Axis III disorders in treatment-resistant major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Does pretreatment insomnia or anxiety predict acute response to bupropion SR?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Does pretreatment anxiety predict response to either bupropion SR or sertraline?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Gender issues in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Predictors of early recovery from major depression among persons admitted to community-based clinics: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Sociodemographic predictors of response to antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Remission onset and relapse in depression. An 18-month prospective study of course for 100 first admission patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Antidepressant response in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11588800-000000000-00000

Early symptom change prediction of remission in depression treatment.

21 January 2018

1 reference

12 December 2020

A neural network model for combining clinical predictors of antidepressant response in mood disorders

1 reference

12 December 2020

Noradrenergic versus serotonergic antidepressants: predictors of treatment response

1 reference

12 December 2020

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder

1 reference

12 December 2020

Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?

1 reference

12 December 2020

Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features

1 reference

12 December 2020

Suicidal ideation and behavior in a general population

1 reference

12 December 2020

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients

1 reference

12 December 2020

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

1 reference

12 December 2020

The patient with comorbid depression and anxiety: the unmet need

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

1 reference

12 December 2020

Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine

1 reference

12 December 2020

SSRIs versus other antidepressants for depressive disorder

1 reference

12 December 2020

Psychosocial and clinical predictors of response to pharmacotherapy for depression

1 reference

12 December 2020

Major depressive disorder and axis I diagnostic comorbidity

1 reference

12 December 2020

Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.

1 reference

12 December 2020

The world health report 2002 - reducing risks, promoting healthy life

1 reference

12 December 2020

Residual symptoms after partial remission: an important outcome in depression

1 reference

12 December 2020

Predictors of antidepressant response

1 reference

12 December 2020

Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures.

1 reference

12 December 2020

Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.

1 reference

12 December 2020

10.2165/11588800-000000000-00000

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018